| (−)− Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78 SP Ermakova, BS Kang, BY Choi, HS Choi, TF Schuster, WY Ma, ... Cancer research 66 (18), 9260-9269, 2006 | 334 | 2006 |
| Novel Optical/Electrochemical Selective 1,2,3-Triazole Ring-Appended Chemosensor for the Al3+ Ion SH Kim, HS Choi, J Kim, SJ Lee, DT Quang, JS Kim Organic letters 12 (3), 560-563, 2010 | 319 | 2010 |
| Standardization of the Korean Version of Patient Health Questionnaire-9 as a Screening Instrument for Major Depressive Disorder. HS Choi, JH Choi, KH Park, KJ Joo, H Ga, HJ Ko, SR Kim Journal of the Korean Academy of Family Medicine 28 (2), 114-119, 2007 | 251 | 2007 |
| Intelligent visual surveillance—a survey IS Kim, HS Choi, KM Yi, JY Choi, SG Kong International Journal of Control, Automation and Systems 8, 926-939, 2010 | 241 | 2010 |
| The intermediate filament protein vimentin is a new target for epigallocatechin gallate S Ermakova, BY Choi, HS Choi, BS Kang, AM Bode, Z Dong Journal of Biological Chemistry 280 (17), 16882-16890, 2005 | 196 | 2005 |
| Effect of fucoidan on aspirin-induced stomach ulceration in rats J Choi, HRB Raghavendran, NY Sung, JH Kim, BS Chun, DH Ahn, ... Chemico-Biological Interactions 183 (1), 249-254, 2010 | 147 | 2010 |
| Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo PL Tran, SA Kim, HS Choi, JH Yoon, SG Ahn BMC cancer 10, 1-9, 2010 | 146 | 2010 |
| Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells CY Han, KB Cho, HS Choi, HK Han, KW Kang Carcinogenesis 29 (9), 1837-1844, 2008 | 128 | 2008 |
| Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells SJ Oh, O Kim, JS Lee, JA Kim, MR Kim, HS Choi, JH Shim, KW Kang, ... Food and Chemical Toxicology 48 (11), 3227-3234, 2010 | 125 | 2010 |
| (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase JH Shim, HS Choi, A Pugliese, SY Lee, JI Chae, BY Choi, AM Bode, ... Journal of Biological Chemistry 283 (42), 28370-28379, 2008 | 124 | 2008 |
| Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation HS Choi, BY Choi, YY Cho, H Mizuno, BS Kang, AM Bode, Z Dong Cancer research 65 (13), 5818-5827, 2005 | 124 | 2005 |
| Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation K Kim, G Kim, JY Kim, HJ Yun, SC Lim, HS Choi Carcinogenesis 35 (6), 1352-1361, 2014 | 121 | 2014 |
| p -HPEA-EDA, a phenolic compound of virgin olive oil, activates AMP-activated protein kinase to inhibit carcinogenesis P Khanal, WK Oh, HJ Yun, GM Namgoong, SG Ahn, SM Kwon, HK Choi, ... Carcinogenesis 32 (4), 545-553, 2011 | 116 | 2011 |
| Fyn is a novel target of (−)‐epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation Z He, F Tang, S Ermakova, M Li, Q Zhao, YY Cho, WY Ma, HS Choi, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2008 | 114 | 2008 |
| Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity JY Kim, SC Lim, G Kim, HJ Yun, SG Ahn, HS Choi Oncogene 34 (38), 4928-4938, 2015 | 102 | 2015 |
| Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in JB6 Cl41 cells NY Lee, SP Ermakova, TN Zvyagintseva, KW Kang, Z Dong, HS Choi Food and chemical Toxicology 46 (5), 1793-1800, 2008 | 100 | 2008 |
| A new poly-Si TFT current-mirror pixel for active matrix organic light emitting diode JH Lee, W Nam, BK Kim, HS Choi, YM Ha, MK Han IEEE Electron Device Letters 27 (10), 830-833, 2006 | 99 | 2006 |
| Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia JW Hong, W Nam, IH Cha, SW Chung, HS Choi, KM Kim, KJ Kim, Y Rhee, ... Osteoporosis International 21, 847-853, 2010 | 96 | 2010 |
| The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity BY Choi, HS Choi, K Ko, YY Cho, F Zhu, BS Kang, SP Ermakova, WY Ma, ... Nature structural & molecular biology 12 (8), 699-707, 2005 | 92 | 2005 |
| The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction YY Cho, Z He, Y Zhang, HS Choi, F Zhu, BY Choi, BS Kang, WY Ma, ... Cancer research 65 (9), 3596-3603, 2005 | 92 | 2005 |
